HSD17B6 and lung cancer: And shorter RFS was also observed in patients with LUAD expressing low levels of HSD17B6 in lung cancer datasets of oncomine and GEO datasets (p < 0.001 for “Okayama Lung”, p = 0.006 for GSE50081, p < 0.001 for GSE68465, respectively) (Fig. 3F, H, J).